{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:03:56Z","timestamp":1784653436662,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-026-04178-5","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:24:57Z","timestamp":1784651097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of varenicline nasal spray in dry eye disease: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"46","author":[{"given":"Sara","family":"Almutawtah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqoub","family":"AlFoudari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad T.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shooq Hussain","family":"Alanezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah R.","family":"Alqussair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Alfailakawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidar","family":"Bonajmah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2337-6588","authenticated-orcid":false,"given":"Abdullah M.","family":"Alharran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"4178_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY et al (2017) Tfos Dews II epidemiology report. Ocul Surf 15:334\u2013365. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.003","journal-title":"Ocul Surf"},{"key":"4178_CR2","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1007\/s10792-022-02320-7","volume":"42","author":"R Huang","year":"2022","unstructured":"Huang R, Su C, Fang L et al (2022) Dry eye syndrome: comprehensive etiologies and recent clinical trials. Int Ophthalmol 42:3253\u20133272. https:\/\/doi.org\/10.1007\/s10792-022-02320-7","journal-title":"Int Ophthalmol"},{"key":"4178_CR3","doi-asserted-by":"publisher","first-page":"108944","DOI":"10.1016\/j.exer.2022.108944","volume":"217","author":"EM Messmer","year":"2022","unstructured":"Messmer EM (2022) Pathophysiology of dry eye disease and novel therapeutic targets. Exp Eye Res 217:108944. https:\/\/doi.org\/10.1016\/j.exer.2022.108944","journal-title":"Exp Eye Res"},{"key":"4178_CR4","unstructured":"Golden MI, Meyer JJ, Zeppieri M, Patel BC (2026) Dry eye syndrome. In: StatPearls, StatPearls Publishing, Treasure Island (FL)"},{"key":"4178_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/2211-5056.369606","volume":"13","author":"A Nguyen","year":"2023","unstructured":"Nguyen A, Kolluru A, Beglarian T (2023) Dry eye disease: a review of anti-inflammatory therapies. Taiwan J Ophthalmol 13:3\u201312. https:\/\/doi.org\/10.4103\/2211-5056.369606","journal-title":"Taiwan J Ophthalmol"},{"key":"4178_CR6","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3390\/ph18070994","volume":"18","author":"J Betz","year":"2025","unstructured":"Betz J, Galor A (2025) Navigating the dry eye therapeutic puzzle: a mechanism-based overview of current treatments. Pharmaceuticals (Basel) 18:994. https:\/\/doi.org\/10.3390\/ph18070994","journal-title":"Pharmaceuticals (Basel)"},{"key":"4178_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10792-024-02978-1","volume":"44","author":"T Shahraki","year":"2024","unstructured":"Shahraki T, Baradaran-Rafii A, Ayyala R et al (2024) New advances in medical management of dry eye: optimizing treatment strategies for enhanced relief. Int Ophthalmol 44:49. https:\/\/doi.org\/10.1007\/s10792-024-02978-1","journal-title":"Int Ophthalmol"},{"key":"4178_CR8","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.3390\/biomedicines11123277","volume":"11","author":"D Borroni","year":"2023","unstructured":"Borroni D, Mazzotta C, Rocha-de-Lossada C et al (2023) Dry eye para-inflammation treatment: evaluation of a novel tear substitute containing hyaluronic acid and low-dose hydrocortisone. Biomedicines 11:3277. https:\/\/doi.org\/10.3390\/biomedicines11123277","journal-title":"Biomedicines"},{"key":"4178_CR9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s40123-023-00868-w","volume":"13","author":"A Ballesteros-S\u00e1nchez","year":"2024","unstructured":"Ballesteros-S\u00e1nchez A, S\u00e1nchez-Gonz\u00e1lez J-M, Tedesco GR et al (2024) Efficacy and safety of quantum molecular resonance electrotherapy in patients with aqueous-deficient, evaporative and mixed-type dry eye: a randomized interventional study. Ophthalmol Ther 13:495\u2013507. https:\/\/doi.org\/10.1007\/s40123-023-00868-w","journal-title":"Ophthalmol Ther"},{"key":"4178_CR10","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/jcm13061618","volume":"13","author":"A Ballesteros-S\u00e1nchez","year":"2024","unstructured":"Ballesteros-S\u00e1nchez A, S\u00e1nchez-Gonz\u00e1lez J-M, Tedesco GR et al (2024) Evaluating GlicoPro tear substitute derived from Helix aspersa snail mucus in alleviating severe dry eye disease: a first-in-human study on corneal esthesiometry recovery and ocular pain relief. J Clin Med 13:1618. https:\/\/doi.org\/10.3390\/jcm13061618","journal-title":"J Clin Med"},{"key":"4178_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s40123-023-00877-9","volume":"13","author":"A Ballesteros-S\u00e1nchez","year":"2024","unstructured":"Ballesteros-S\u00e1nchez A, S\u00e1nchez-Gonz\u00e1lez J-M, Borrone MA et al (2024) The influence of lid-parallel conjunctival folds and conjunctivochalasis on dry eye symptoms with and without contact lens wear: a review of the literature. Ophthalmol Ther 13:651\u2013670. https:\/\/doi.org\/10.1007\/s40123-023-00877-9","journal-title":"Ophthalmol Ther"},{"key":"4178_CR12","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/jcm11051424","volume":"11","author":"C Garc\u00eda-L\u00f3pez","year":"2022","unstructured":"Garc\u00eda-L\u00f3pez C, G\u00f3mez-Huertas C, S\u00e1nchez-Gonz\u00e1lez J-M et al (2022) Opioids and ocular surface pathology: a literature review of new treatments horizons. J Clin Med 11:1424. https:\/\/doi.org\/10.3390\/jcm11051424","journal-title":"J Clin Med"},{"key":"4178_CR13","doi-asserted-by":"publisher","first-page":"102992","DOI":"10.1016\/j.xcrp.2025.102992","volume":"6","author":"SG Aiken","year":"2025","unstructured":"Aiken SG, Fiorito D, Harper M et al (2025) Understanding varenicline function via key receptor and ligand interactions. Cell Rep Phys Sci 6:102992. https:\/\/doi.org\/10.1016\/j.xcrp.2025.102992","journal-title":"Cell Rep Phys Sci"},{"key":"4178_CR14","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s40265-022-01782-4","volume":"82","author":"JE Frampton","year":"2022","unstructured":"Frampton JE (2022) Varenicline solution nasal spray: a review in dry eye disease. Drugs 82:1481\u20131488. https:\/\/doi.org\/10.1007\/s40265-022-01782-4","journal-title":"Drugs"},{"key":"4178_CR15","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1097\/ICO.0000000000002941","volume":"41","author":"D Wirta","year":"2022","unstructured":"Wirta D, Torkildsen GL, Boehmer B et al (2022) Onset-1 phase 2b randomized trial to evaluate the safety and efficacy of OC-01 (varenicline solution) nasal spray on signs and symptoms of dry eye disease. Cornea 41:1207\u20131216. https:\/\/doi.org\/10.1097\/ICO.0000000000002941","journal-title":"Cornea"},{"key":"4178_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ophtha.2021.11.004","volume":"129","author":"D Wirta","year":"2022","unstructured":"Wirta D, Vollmer P, Paauw J et al (2022) Efficacy and safety of OC-01 (varenicline solution) nasal spray on signs and symptoms of dry eye disease. Ophthalmology 129:379\u2013387. https:\/\/doi.org\/10.1016\/j.ophtha.2021.11.004","journal-title":"Ophthalmology"},{"key":"4178_CR17","doi-asserted-by":"publisher","first-page":"101032","DOI":"10.1016\/j.lanwpc.2024.101032","volume":"45","author":"L Tian","year":"2024","unstructured":"Tian L, Jin X, Wang J et al (2024) Varenicline solution nasal spray for dry eye disease in Chinese patients: a randomized phase 3 trial. Lancet Reg Health West Pac 45:101032. https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101032","journal-title":"Lancet Reg Health West Pac"},{"key":"4178_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jtos.2025.07.010","volume":"38","author":"L Tong","year":"2025","unstructured":"Tong L, Liu Z, \u015eahin A et al (2025) Topical pharmacologic treatments for dry eye disease: a systematic review. Ocul Surf 38:302\u2013317. https:\/\/doi.org\/10.1016\/j.jtos.2025.07.010","journal-title":"Ocul Surf"},{"key":"4178_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12886-023-03069-y","volume":"23","author":"B Bashrahil","year":"2023","unstructured":"Bashrahil B, Taher N, Alzahrani Z et al (2023) The efficacy and safety of varenicline nasal spray for the management of dry eye signs: a systematic review and meta-analysis. BMC Ophthalmol 23:319. https:\/\/doi.org\/10.1186\/s12886-023-03069-y","journal-title":"BMC Ophthalmol"},{"key":"4178_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1002\/14651858.ED000142","journal-title":"BMJ"},{"key":"4178_CR21","doi-asserted-by":"publisher","unstructured":"Cumpston M, Li T, Page MJ, et al Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Library. https:\/\/doi.org\/10.1002\/14651858.ED000142","DOI":"10.1002\/14651858.ED000142"},{"key":"4178_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5:210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"4178_CR23","doi-asserted-by":"publisher","first-page":"852","DOI":"10.5195\/jmla.2023.1803","volume":"111","author":"T Gotschall","year":"2023","unstructured":"Gotschall T (2023) Resource review: endnote 21 desktop version. J Med Libr Assoc 111:852\u2013853. https:\/\/doi.org\/10.5195\/jmla.2023.1803","journal-title":"J Med Libr Assoc"},{"key":"4178_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"4178_CR25","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924\u2013926","journal-title":"BMJ"},{"key":"4178_CR26","doi-asserted-by":"publisher","first-page":"10916","DOI":"10.1002\/ece3.6747","volume":"10","author":"CJ Lortie","year":"2020","unstructured":"Lortie CJ, Filazzola A (2020) A contrast of meta and metafor packages for meta-analyses in R. Ecol Evol 10:10916\u201310921. https:\/\/doi.org\/10.1002\/ece3.6747","journal-title":"Ecol Evol"},{"key":"4178_CR27","unstructured":"Harrer M Cuijpers, P, Furukawa, T, Ebert, DD (2019) Companion R package for the guide doing meta-analysis in R. https:\/\/dmetar.protectlab.org\/. Accessed 13 Mar 2026"},{"key":"4178_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jtos.2021.12.007","volume":"24","author":"H Quiroz-Mercado","year":"2022","unstructured":"Quiroz-Mercado H, Hernandez-Quintela E, Chiu KH et al (2022) A phase II randomized trial to evaluate the long-term (12-week) efficacy and safety of OC-01 (varenicline solution) nasal spray for dry eye disease: the MYSTIC study. Ocul Surf 24:15\u201321. https:\/\/doi.org\/10.1016\/j.jtos.2021.12.007","journal-title":"Ocul Surf"},{"key":"4178_CR29","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s40123-025-01118-x","volume":"14","author":"TJ Ferguson","year":"2025","unstructured":"Ferguson TJ, Durgan D, Whitt T, Swan RJ (2025) Varenicline nasal spray for the treatment of dry eye disease following corneal collagen crosslinking. Ophthalmol Ther 14:959\u2013968. https:\/\/doi.org\/10.1007\/s40123-025-01118-x","journal-title":"Ophthalmol Ther"},{"key":"4178_CR30","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s40123-024-00949-4","volume":"13","author":"TJ Ferguson","year":"2024","unstructured":"Ferguson TJ, Messer B, Risbrudt N et al (2024) Varenicline solution nasal spray for the treatment of dry eye disease following LASIK. Ophthalmol Ther 13:1693\u20131701. https:\/\/doi.org\/10.1007\/s40123-024-00949-4","journal-title":"Ophthalmol Ther"},{"key":"4178_CR31","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.2147\/OPTH.S474747","volume":"18","author":"T Ferguson","year":"2024","unstructured":"Ferguson T, Walton K, Goertz J, Baartman B (2024) Varenicline solution nasal spray 0.03\u00a0Mg for the treatment of dry eye disease following photorefractive keratectomy. OPTH 18:2777\u20132784. https:\/\/doi.org\/10.2147\/OPTH.S474747","journal-title":"OPTH"},{"key":"4178_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1124\/jpet.112.194852","volume":"342","author":"T Bordia","year":"2012","unstructured":"Bordia T, Hrachova M, Chin M et al (2012) Varenicline is a potent partial agonist at \u03b16\u03b22* nicotinic acetylcholine receptors in rat and monkey striatum. J Pharmacol Exp Ther 342:327\u2013334. https:\/\/doi.org\/10.1124\/jpet.112.194852","journal-title":"J Pharmacol Exp Ther"},{"key":"4178_CR33","doi-asserted-by":"publisher","unstructured":"Aiken SG, Fiorito D, Harper M, et al (2025) How varenicline works: identifying critical receptor and ligand-based interactions. https:\/\/doi.org\/10.1101\/2025.06.14.659675","DOI":"10.1101\/2025.06.14.659675"},{"key":"4178_CR34","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2147\/OPTH.S403953","volume":"17","author":"JM Schallhorn","year":"2023","unstructured":"Schallhorn JM, McGee S, Nau J et al (2023) OC-01 (varenicline solution) nasal spray for the treatment of dry eye disease signs and symptoms in subjects with autoimmune disease: integrated data from ONSET-1 and ONSET-2. OPTH 17:725\u2013734. https:\/\/doi.org\/10.2147\/OPTH.S403953","journal-title":"OPTH"},{"key":"4178_CR35","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2147\/OPTH.S512364","volume":"19","author":"A Gupta","year":"2025","unstructured":"Gupta A, Linaburg T, Iacobucci E et al (2025) Varenicline solution nasal spray for the treatment of dry eye disease in Sjogren\u2019s disease: a pilot study. OPTH 19:1073\u20131084. https:\/\/doi.org\/10.2147\/OPTH.S512364","journal-title":"OPTH"},{"key":"4178_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.preteyeres.2012.02.003","volume":"31","author":"S Barabino","year":"2012","unstructured":"Barabino S, Chen Y, Chauhan S, Dana R (2012) Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res 31:271\u2013285. https:\/\/doi.org\/10.1016\/j.preteyeres.2012.02.003","journal-title":"Prog Retin Eye Res"},{"key":"4178_CR37","doi-asserted-by":"publisher","first-page":"69377","DOI":"10.12775\/JEHS.2026.88.69377","volume":"88","author":"JM Sapikowski","year":"2026","unstructured":"Sapikowski JM, Juchniewicz A, Janiszewska M et al (2026) Beyond artificial tears: a new era in dry eye disease management\u2013a review article. J Educ Health Sport 88:69377. https:\/\/doi.org\/10.12775\/JEHS.2026.88.69377","journal-title":"J Educ Health Sport"},{"key":"4178_CR38","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/pharmaceutics15030990","volume":"15","author":"H Mondal","year":"2023","unstructured":"Mondal H, Kim H-J, Mohanto N, Jee J-P (2023) A review on dry eye disease treatment: recent progress, diagnostics, and future perspectives. Pharmaceutics 15:990. https:\/\/doi.org\/10.3390\/pharmaceutics15030990","journal-title":"Pharmaceutics"},{"key":"4178_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/OPTO.S350185","volume":"15","author":"DA Semp","year":"2023","unstructured":"Semp DA, Beeson D, Sheppard AL et al (2023) Artificial tears: a systematic review. OPTO 15:9\u201327. https:\/\/doi.org\/10.2147\/OPTO.S350185","journal-title":"OPTO"},{"key":"4178_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12886-015-0122-z","volume":"15","author":"A Sy","year":"2015","unstructured":"Sy A, O\u2019Brien KS, Liu MP et al (2015) Expert opinion in the management of aqueous deficient dry eye disease (DED). BMC Ophthalmol 15:133. https:\/\/doi.org\/10.1186\/s12886-015-0122-z","journal-title":"BMC Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04178-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04178-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04178-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:24:59Z","timestamp":1784651099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04178-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4178"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04178-5","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"302"}}